BRIEF

on MediClin AG (isin : DE0006595101)

MEDICLIN Reports Growth in Sales and Operating Results for Q1 2024

MEDICLIN Aktiengesellschaft, a healthcare provider, announced a 4.9% increase in consolidated sales reaching EUR 185.4 million for the first quarter of 2024. This improvement is accompanied by a rise in the operating profit from EUR -1.7 million in 2023 to EUR 4.1 million in the same period of 2024.

The company reported an overall capacity utilization of 85.1%, compared to 82.4% in the first three months of 2023. These figures represent a solid start to the year, indicating efficient operations and enhanced service delivery. Additionally, MEDICLIN finalized key transitions including the sale of MEDICLIN Herzzentrum Coswig and the acquisition of Reha-Klinik am Sendesaal in Bremen, signaling a strategic focus on rehabilitation services.

In segment performance, the post-acute units saw a 6.4% increase in sales, while the acute segment showed modest growth. The other activities and reconciliation segment reported a notable increase of 25.2% in sales, albeit with a slight decline in operating profit.

MEDICLIN's first-quarter results suggest a positive shift in financial health and operational efficiency, setting a constructive tone for the remainder of 2024. The company remains focused on strengthening its core competencies in rehabilitation and outpatient care, as evidenced by its recent business activities.

R. E.

Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.

Click here to consult the press release on which this article is based

See all MediClin AG news